Dr. Schiffman is a pediatric hematologist-oncologist and co-founder/CEO of PEEL Therapeutics headquartered in Salt Lake City, UT, USA and Haifa, Israel. It's a clinical-stage biotech company with a serendipitous origin story and a bright future. The company's name is the Hebrew word for elephant—an animal with amazing cancer-fighting genes that ignited the imaginations of Dr. Schiffman and his partners, sparking a new approach to fighting disease in humans starting with cancer and inflammatory diseases. PEEL's work is inspired by evolution and focuses on the science and the interconnectedness of all life on Earth. They aim to turn millions of years of evolution into the medicine humans need today.This content is offered for informational purposes only. The opinions stated in this podcast are that of the speaker and do not constitute or imply an endorsement by Thermo Fisher Scientific.